Panbela Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PBLA and buy or sell other stocks, ETFs, and their options commission-free!About PBLA
Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis.
CEOJennifer K. Simpson
CEOJennifer K. Simpson
Employees6
Employees6
HeadquartersWaconia, Minnesota
HeadquartersWaconia, Minnesota
Founded2011
Founded2011
Employees6
Employees6
PBLA Key Statistics
Market cap17.62M
Market cap17.62M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume15.79K
Average volume15.79K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.27
52 Week high$4.27
52 Week low$1.25
52 Week low$1.25
Stock Snapshot
Panbela Therapeutics(PBLA) stock is priced at $1.31, giving the company a market capitalization of 17.62M.
Panbela Therapeutics(PBLA) stock opened on 2025-12-14 at —. The price climbed to — and dipped to —.
Panbela Therapeutics(PBLA) shares are trading with a volume of 0, against a daily average of 15.79K.
In the last year, Panbela Therapeutics(PBLA) shares hit a 52-week high of $4.27 and a 52-week low of $1.25.
In the last year, Panbela Therapeutics(PBLA) shares hit a 52-week high of $4.27 and a 52-week low of $1.25.
People also own
Based on the portfolios of people who own PBLA. This list is generated using Robinhood data, and it’s not a recommendation.